Melittin attenuates liver injury in thioacetamide-treated mice through modulating inflammation and fibrogenesis

Experimental Biology and Medicine

Volumn 236, Issue 11, 2011, Pages 1306-1313

  Park, Ji Hyun ^a   Kum, Yoon Seup ^a   Lee, Tae Im ^a   Kim, Soo Jung ^a   Lee, Woo Ram ^a   Kim, Bong Il ^b   Kim, Hyun Soo ^c   Kim, Kyung Hyun ^a   Park, Kwan Kyu ^a  

^a Department of Pathology ^*  (South Korea)

^b Catholic University of Daegu   (South Korea)

^c Keimyung University   (South Korea)

Author keywords

Inflammation; Liver fibrosis; Melittin; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELITTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FIBROGENESIS; HEPATITIS; INFLAMMATION; LIVER FIBROSIS; LIVER INJURY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STELLATE CELL;

ANIMALS; BEE VENOMS; HEPATIC STELLATE CELLS; LIVER; LIVER CIRRHOSIS; MELITTEN; MICE; MICE, INBRED C57BL; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; THIOACETAMIDE; TUMOR NECROSIS FACTOR-ALPHA;

APIS MELLIFERA; MUS;

EID: 80055114126     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011127     Document Type: Article

References (49)

1. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003;38(Suppl. 1):S38-53
2. Friedman SL, Bansal MB. Reversal of hepatic fibrosis - fact or fantasy? Hepatology 2006;43:S82-8
3. Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004;1:98-105
4. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985;82:8681-5
5. Otto DA, Veech RL. Isolation of a lipocyte-rich fraction from rat liver nonparenchymal cells. Adv Exp Med Biol 1980;132:509-17
6. Maher JJ, Bissell DM, Friedman SL, Roll FJ. Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer. J Clin Invest 1988;82:450-9
7. Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990;86:1641-8
8. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18
9. Knittel T, Kobold D, Dudas J, Saile B, Ramadori G. Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture. Am J Pathol 1999;155:1841-8
10. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Hepatic fibrosis: molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol 2005;45:605-28
11. Xu LM. Treatment of liver fibrosis and liver cirrhosis with traditional Chinese medicine. Zhonghua Gan Zang Bing Za Zhi 2008;16:182-3
12. Habermann E. Bee and wasp venoms. Science 1972;177:314-22
13. Hider RC. Honeybee venom: a rich source of pharmacologically active peptides. Endeavour 1988;12:60-5
14. Dempsey CE. The actions of melittin on membranes. Biochim Biophys Acta 1990;1031:143-61
15. Martin W, Hartter P. Basic peptides in bee venom, VI. Structure-activity studies on the anti-inflammatory effects of derivatives and fragments of the MCD-peptide (author's transl). Hoppe Seylers Z Physiol Chem 1980;361:525-35
16. Koburova KL, Michailova SG, Shkenderov SV. Further investigation on the antiinflammatory properties of adolapin - bee venom polypeptide. Acta Physiol Pharmacol Bulg 1985;11:50-5
17. Kwon YB, Lee JD, Lee HJ, Han HJ, Mar WC, Kang SK, Beitz AJ, Lee JH. Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain 2001;90:271-80
18. Jang HS, Kim SK, Han JB, Ahn HJ, Bae H, Min BI. Effects of bee venom on the pro-inflammatory responses in RAW264.7 macrophage cell line. J Ethnopharmacol 2005;99:157-60
19. Saini SS, Peterson JW, Chopra AK. Melittin binds to secretory phospholipase A2 and inhibits its enzymatic activity. Biochem Biophys Res Commun 1997;238:436-42
20. Dashti H, Jeppsson B, Hagerstrand I, Hultberg B, Srinivas U, Abdulla M, Bengmark S. Thioacetamide- and carbon tetrachloride-induced liver cirrhosis. Eur Surg Res 1989;21:83-91
21. Noda S, Masumi S, Moriyama M, Kannan Y, Ohta M, Sugano T, Yamate J. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats. Hepatology 1996;24:412-8
22. Perez Tamayo R. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology 1983;3:112-20
23. Marinos G, Naoumov NV, Rossol S, Torre F, Wong PY, Gallati H, Portmann B,Williams R. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology 1995;108:1453-63
24. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H, Fuchs D. Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis. Hepatology 1995;21:976-8
25. Balkan J, Dogru-Abbasoglu S, Kanbagli O, Cevikbas U, Aykac-Toker G, Uysal M. Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum Exp Toxicol 2001;20:251-4
26. Bruck R, Shirin H, Aeed H, Matas Z, Hochman A, Pines M, Avni Y. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J Hepatol 2001;35:457-64
27. Bruck R, Schey R, Aeed H, Hochman A, Genina O, Pines M. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis. Liver Int 2004;24:169-76
28. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000;21:49-98
29. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001;21:351-72
30. Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004;40:860-7
31. Raghuraman H, Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Biosci Rep 2007;27:189-223
32. Pratt JP, Ravnic DJ, Huss HT, Jiang X, Orozco BS, Mentzer SJ. Melittin-induced membrane permeability: a nonosmotic mechanism of cell death. In Vitro Cell Dev Biol Anim 2005;41:349-55
33. Han S, Lee K, Yeo J, Kweon H, Woo S, Lee M, Baek H, Kim S, Park K. Effect of honey bee venom on microglial cells nitric oxide and tumor necrosis factor-alpha production stimulated by LPS. J Ethnopharmacol 2007;111:176-81
34. Park JH, Kim KH, Kim SJ, Lee WR, Lee KG, Park KK. Effect of bee venom on transforming growth factor-beta1-treated hepatocytes. Int J Toxicol 2010;29:49-56
35. Kim SJ, Park JH, Kim KH, Lee WR, Chang YC, Park KK, Lee KG, Han SM, Yeo JH, Pak SC. Bee venom inhibits hepatic fibrosis through suppression of pro-fibrogenic cytokine expression. Am J Chin Med 2010;38:921-35
36. Marra F. Chemokines in liver inflammation and fibrosis. Front Biosci 2002;7:d1899-914
37. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-52
38. Burra P, Hubscher SG, Shaw J, Elias E, Adams DH. Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? Gut 1992;33:268-71
39. Jaeschke H. Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 1997;273:G602-11
40. Ip E, Farrell G, Hall P, Robertson G, Leclercq I. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 2004;39:1286-96
41. Simeonova PP, Gallucci RM, Hulderman T, Wilson R, Kommineni C, Rao M, Luster MI. The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol Appl Pharmacol 2001;177:112-20
42. Essani NA, Bajt ML, Farhood A, Vonderfecht SL, Jaeschke H. Transcriptional activation of vascular cell adhesion molecule-1 gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Immunol 1997;158:5941-8
43. Essani NA, Fisher MA, Farhood A, Manning AM, Smith CW, Jaeschke H. Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 1995;21:1632-9
44. Essani NA, Fisher MA, Jaeschke H. Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 1997;7:90-6
45. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71
46. Thanos D, Maniatis T. NF-kappa B: a lesson in family values. Cell 1995;80:529-32
47. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-66
48. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001;35:297-306
49. Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta 2006;364:33-60